Cellebrite lines up Feb. 11 earnings call before U.S. market open - Stock Titan

Cellebrite to Report Fourth-Quarter and Fiscal Year 2025 Financial Results on February 11, 2026 Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags earnings date Rhea-AI Summary Cellebrite (NASDAQ: CLBT) announced it will report fourth-quarter and fiscal year 2025 financial results before U.S. markets open on Wednesday, February 11, 2026. A live conference call and webcast to review Q4 2025 results and discuss the company’s 2026 outlook will follow at 8:30 a.m. ET the same day. Call-in numbers, conference ID CLBTQ425, and live webcast links are provided; historical financial tables and supplemental data will be posted to the company’s quarterly results page on the investor relations website. News Market Reaction – CLBT -3.91% 1 alert -3.91% NEWS EFFECT On the day this news was published, CLBT declined 3.91%, reflecting a moderate negative market reaction. Data tracked by StockTitan Argus on the day of publication. Key Figures Earnings release date: February 11, 2026 Earnings call time: 8:30 a.m. ET Call-in number (US): 800-274-8461 +5 more 8 metrics EARNINGS RELEASE DATE February 11, 2026 Scheduled Q4 and FY25 financial results announcement EARNINGS CALL TIME 8:30 a.m. ET Start time of Q4 2025 conference call CALL-IN NUMBER (US) 800-274-8461 Domestic dial-in for earnings call CALL-IN NUMBER (INTL.) 203-518-9814 International dial-in for earnings call CONFERENCE ID CLBTQ425 Identifier for Q4 2025 results call CURRENT PRICE $16.38 Pre-announcement trading level 52-WEEK HIGH $26.30 52-week trading range high before earnings date news 52-WEEK LOW $13.10 52-week trading range low before earnings date news Market Reality Check Price: $14.69 Vol: Volume 1,474,698 vs 20-da... high vol $14.69 LAST CLOSE VOLUME Volume 1,474,698 vs 20-day average 834,972; relative volume 1.77x ahead of the earnings date announcement. HIGH TECHNICAL Price $16.38 is trading below the 200-day MA of $17.18 before the Q4/FY25 results date. Peers on Argus CLBT was down 3.65% while key software peers showed mixed, mostly modest moves: ... CLBT was down 3.65% while key software peers showed mixed, mostly modest moves: AVPT +0.16%, BOX +0.43%, CALX +0.37%, PAY -0.66%, QLYS -0.98%, suggesting a stock-specific reaction rather than a broad sector move. Historical Context 5 past events · Latest: Dec 02 (Positive) Pattern 5 events DATE EVENT SENTIMENT MOVE CATALYST Dec 02 Acquisition completed Positive +3.9% Closed Corellium acquisition to enhance AI-powered digital investigation platform. Nov 12 Q3 2025 results Positive +1.7% Reported strong ARR and revenue growth with reiterated 2025 guidance. Oct 30 Leadership change Neutral -1.3% Appointed new General Counsel and Chief Compliance Officer. Oct 28 User summit update Neutral -0.1% Announced 2026 C2C User Summit featuring advocacy-focused keynote. Oct 17 Earnings date notice Neutral +0.4% Set date and time to report Q3 2025 results and outlook. PATTERN DETECTED Recent substantive news (acquisition, Q3 results) was followed by positive price reactions, while organizational or event-related updates had muted to slightly negative impacts. RECENT COMPANY HISTORY Over the last few months, Cellebrite reported strong Q3 2025 metrics with double‑digit ARR and revenue growth and reiterated full‑year 2025 guidance, which was followed by a positive price reaction. It then completed the $170M Corellium acquisition, again with a positive move. Governance and branding items, including a new General Counsel and the C2C User Summit 2026 announcement, saw limited share-price impact. The prior Q3 earnings date notice also drew only a small reaction. Market Pulse Summary This announcement set February 11, 2026 for Cellebrite’s Q4 and full‑year 2025 results and outlined ... Analysis This announcement set February 11, 2026 for Cellebrite’s Q4 and full‑year 2025 results and outlined access details for the 8:30 a.m. ET conference call and webcast. In recent quarters, updates on execution and M&A, including Q3 2025 results and the Corellium acquisition, were followed by constructive price reactions. Looking ahead, investors would likely focus on ARR, revenue growth, profitability metrics, and any 2026 outlook commentary released on that date. AI-generated analysis. Not financial advice. 01/21/2026 - 09:00 AM TYSONS CORNER, Va. and PETAH TIKVA, Israel, Jan. 21, 2026 /PRNewswire/ -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced it will report its fourth-quarter and fiscal year 2025 financial results before the U.S. markets open on Wednesday, February 11, 2026. Later that same morning, Cellebrite will host a live conference call and webcast to review the Company's financial results for the fourth quarter of 2025 and discuss its 2026 outlook. Relevant details include: Date: Wednesday, February 11, 2026 Time: 8:30 a.m. ET Call-In Number: 203-518-9814 / 800-274-8461 Conference ID:   CLBTQ425 Event URL: https://investors.cellebrite.com/events/event-details/cellebrite-q4-2025-financial-results-conference-call-webcast Live Webcast URL: https://edge.media-server.com/mmc/p/v9sjjqnr In conjunction with the conference call and webcast, historical financial tables and supplemental data will be available on the quarterly results section of Company's investor relations website at https://investors.cellebrite.com/financial-information/quarterly-results. About Cellebrite Cellebrite's (Nasdaq: CLBT) mission is to protect communities, nations and businesses as a global leader in digital investigative and intelligence solutions. More than 7,000 global law enforcement agencies, defense and intelligence organizations and enterprises trust Cellebrite's AI-powered software portfolio to make forensically sound digital data more accessible and actionable. Cellebrite technology allows customers to accelerate more than 1.5 million legally sanctioned investigations annually, enhance sovereign security, elevate operational efficacy and efficiency and enable advanced mobile research and application security. Available via cloud, on-premises and hybrid deployments, Cellebrite's technology enables its customers around the globe to advance their missions, elevate public safety and safeguard data privacy. To learn more, visit us at www.cellebrite.com, https://investors.cellebrite.com/investors and find us on social media @Cellebrite. Investor Relations Andrew Kramer Vice President, Investor Relations investors@cellebrite.com +1 973.206.7760 Media Victor Cooper Sr. Director of Corporate Communications Victor.cooper@cellebrite.com +1 404.804.5910 SOURCE Cellebrite FAQ When will Cellebrite (CLBT) release Q4 and fiscal year 2025 results? Cellebrite will release results before U.S. markets open on February 11, 2026. What time is the Cellebrite (CLBT) Q4 2025 conference call and webcast on February 11, 2026? The live conference call and webcast is scheduled for 8:30 a.m. ET on February 11, 2026. How can investors join the Cellebrite (CLBT) Q4 2025 call and webcast? Investors can call 203-518-9814 or 800-274-8461 with conference ID CLBTQ425, or access the live webcast via the provided investor webcast URL. Where will Cellebrite (CLBT) post historical financial tables and supplemental data for Q4 2025? Historical financial tables and supplemental data will be available on the company’s quarterly results section of its investor relations website. Will Cellebrite (CLBT) discuss 2026 guidance during the February 11, 2026 call? Yes; the company will review Q4 2025 results and discuss its 2026 outlook during the call and webcast.